|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/40 | |
| A61P 3/06 | |||
| A61K 39/395 | |||
| A61K 45/06 | |||
| A61K 31/22 | |||
| A61K 31/366 | |||
| A61K 31/40 | |||
| A61K 31/405 | |||
| A61K 31/44 | |||
| A61K 31/505 | |||
| A61K 31/66 | |||
| A61K 31/47 | |||
| A61K 39/00 |
| (11) | Number of the document | 2641917 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13151352.5 |
| Date of filing the European patent application | 2008-08-22 | |
| (97) | Date of publication of the European application | 2013-09-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 86133 P | 2008-08-04 | US |
| (72) |
Jackson, Simon Mark, US
Walker, Nigel Pelham Clinton, US
Piper, Derek Evan, US
Shan, Bei, US
Shen, Wenyan, US
Chan, Joyce Chi Yee, US
King, Chadwick Terence, CA
Ketchem, Randal Robert, US
Mehlin, Christopher, US
Carabeo, Teresa Arazas, US
Cao, Qiong, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
|
| (54) | Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |
| Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9) |